Cholinesterase Inhibition Activity and Docking Simulation Study of Coumarin Mannich Base Derivatives

Inhibition of acetylcholinesterase and butyrylcholinesterase (AChE and BuChE) as two major forms of cholinesterases (ChEs) is considered as the common approach for the treatment of Alzheimer's disease (AD). The present study was done to explore the anticholinesterase inhibition property of coum...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali Kiani, Leili Jalili-baleh, Zahra Abdollahi, Hamid Nadri, Alireza Foroumadi, Seyed Esmaeil Sadat Ebrahimi, Mehdi Khoobi
Format: Article
Language:English
Published: University of Tehran 2019-01-01
Series:Journal of Sciences, Islamic Republic of Iran
Subjects:
Online Access:https://jsciences.ut.ac.ir/article_69627_5849f8f2f225aebc917e6b922c874ea0.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850152709889458176
author Ali Kiani
Leili Jalili-baleh
Zahra Abdollahi
Hamid Nadri
Alireza Foroumadi
Seyed Esmaeil Sadat Ebrahimi
Mehdi Khoobi
author_facet Ali Kiani
Leili Jalili-baleh
Zahra Abdollahi
Hamid Nadri
Alireza Foroumadi
Seyed Esmaeil Sadat Ebrahimi
Mehdi Khoobi
author_sort Ali Kiani
collection DOAJ
description Inhibition of acetylcholinesterase and butyrylcholinesterase (AChE and BuChE) as two major forms of cholinesterases (ChEs) is considered as the common approach for the treatment of Alzheimer's disease (AD). The present study was done to explore the anticholinesterase inhibition property of coumarin Mannich base derivatives. A series of cumarin Manich bases were synthesized (4a-h) through one-pot tri-component reaction in an environmentally friendly condition and evaluated against AChE and BuChE by Ellman's assay. Ligand-protein docking simulation was also performed for the most active compound 4a. Additionally, the criteria of drug likeness of the target compounds was predicted using SwissADME web service. All compounds exhibited weak to moderate inhibitory activity against both AChE and BuChE enzymes. Compound 4a containing p-tolyl piperazin group showed the best activity against AChE (42.4 % at 32 µM), while compound 4g bearing phenylpiperazine moiety was the best BuChE inhibitor (43.9% at 32 µM). Ligand-protein docking simulation also exhibited that the main part of compound 4a in ChE inhibitory activity is amine moiety. Moreover, the prediction of "Lipinski's rule of five" showed that most target compounds can cross the BBB and have properties that would make them likely orally active compounds in humans. This study suggested that the synthesized cumarin Manich bases with some more structural modifications may be considered as a potential compound to target AChE and BuChE.
format Article
id doaj-art-48141ab3ca0d4cb48b8eb24beb4c888d
institution OA Journals
issn 1016-1104
2345-6914
language English
publishDate 2019-01-01
publisher University of Tehran
record_format Article
series Journal of Sciences, Islamic Republic of Iran
spelling doaj-art-48141ab3ca0d4cb48b8eb24beb4c888d2025-08-20T02:25:54ZengUniversity of TehranJournal of Sciences, Islamic Republic of Iran1016-11042345-69142019-01-0130151210.22059/jsciences.2019.256053.100724769627Cholinesterase Inhibition Activity and Docking Simulation Study of Coumarin Mannich Base DerivativesAli Kiani0Leili Jalili-baleh1Zahra Abdollahi2Hamid Nadri3Alireza Foroumadi4Seyed Esmaeil Sadat Ebrahimi5Mehdi Khoobi6Department of medical Chemistry, school of pharmacy, International campus, Tehran University of Medical Science (IC-TUMS),Tehran, Iran.The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran 1417614411, IranDepartment of Medicinal Chemistry, Faculty of pharmacy and Pharmaceutical sciences research center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.Department of Medicinal Chemistry, Faculty of pharmacy and Pharmaceutical sciences research center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.Tehran University of Medical SciencesDepartment of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, IranInhibition of acetylcholinesterase and butyrylcholinesterase (AChE and BuChE) as two major forms of cholinesterases (ChEs) is considered as the common approach for the treatment of Alzheimer's disease (AD). The present study was done to explore the anticholinesterase inhibition property of coumarin Mannich base derivatives. A series of cumarin Manich bases were synthesized (4a-h) through one-pot tri-component reaction in an environmentally friendly condition and evaluated against AChE and BuChE by Ellman's assay. Ligand-protein docking simulation was also performed for the most active compound 4a. Additionally, the criteria of drug likeness of the target compounds was predicted using SwissADME web service. All compounds exhibited weak to moderate inhibitory activity against both AChE and BuChE enzymes. Compound 4a containing p-tolyl piperazin group showed the best activity against AChE (42.4 % at 32 µM), while compound 4g bearing phenylpiperazine moiety was the best BuChE inhibitor (43.9% at 32 µM). Ligand-protein docking simulation also exhibited that the main part of compound 4a in ChE inhibitory activity is amine moiety. Moreover, the prediction of "Lipinski's rule of five" showed that most target compounds can cross the BBB and have properties that would make them likely orally active compounds in humans. This study suggested that the synthesized cumarin Manich bases with some more structural modifications may be considered as a potential compound to target AChE and BuChE.https://jsciences.ut.ac.ir/article_69627_5849f8f2f225aebc917e6b922c874ea0.pdfalzheimer’s diseaseacetylcholinesterasebutyrylcholinesterse4-hydroxycoumarinmannich base
spellingShingle Ali Kiani
Leili Jalili-baleh
Zahra Abdollahi
Hamid Nadri
Alireza Foroumadi
Seyed Esmaeil Sadat Ebrahimi
Mehdi Khoobi
Cholinesterase Inhibition Activity and Docking Simulation Study of Coumarin Mannich Base Derivatives
Journal of Sciences, Islamic Republic of Iran
alzheimer’s disease
acetylcholinesterase
butyrylcholinesterse
4-hydroxycoumarin
mannich base
title Cholinesterase Inhibition Activity and Docking Simulation Study of Coumarin Mannich Base Derivatives
title_full Cholinesterase Inhibition Activity and Docking Simulation Study of Coumarin Mannich Base Derivatives
title_fullStr Cholinesterase Inhibition Activity and Docking Simulation Study of Coumarin Mannich Base Derivatives
title_full_unstemmed Cholinesterase Inhibition Activity and Docking Simulation Study of Coumarin Mannich Base Derivatives
title_short Cholinesterase Inhibition Activity and Docking Simulation Study of Coumarin Mannich Base Derivatives
title_sort cholinesterase inhibition activity and docking simulation study of coumarin mannich base derivatives
topic alzheimer’s disease
acetylcholinesterase
butyrylcholinesterse
4-hydroxycoumarin
mannich base
url https://jsciences.ut.ac.ir/article_69627_5849f8f2f225aebc917e6b922c874ea0.pdf
work_keys_str_mv AT alikiani cholinesteraseinhibitionactivityanddockingsimulationstudyofcoumarinmannichbasederivatives
AT leilijalilibaleh cholinesteraseinhibitionactivityanddockingsimulationstudyofcoumarinmannichbasederivatives
AT zahraabdollahi cholinesteraseinhibitionactivityanddockingsimulationstudyofcoumarinmannichbasederivatives
AT hamidnadri cholinesteraseinhibitionactivityanddockingsimulationstudyofcoumarinmannichbasederivatives
AT alirezaforoumadi cholinesteraseinhibitionactivityanddockingsimulationstudyofcoumarinmannichbasederivatives
AT seyedesmaeilsadatebrahimi cholinesteraseinhibitionactivityanddockingsimulationstudyofcoumarinmannichbasederivatives
AT mehdikhoobi cholinesteraseinhibitionactivityanddockingsimulationstudyofcoumarinmannichbasederivatives